{"id":"https://genegraph.clinicalgenome.org/r/15e2fbef-7afa-4aaa-a8a8-69906bfb96f7v1.1","type":"EvidenceStrengthAssertion","dc:description":"DPAGT1 was first reported in relation to autosomal recessive congenital disorder of glycosylation in 2003 (Wu, et al., PMID: 12872255), and autosomal recessive congenital myasthenic syndrome in 2012 (Belaya, et al., PMID: 22742743). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism(s), inheritance pattern, or phenotypic variability. Therefore, both disease entities have been lumped into one disease entity. 27 variants (missense, in-frame indel, nonsense, frameshift, and splice) that have been reported in 16 probands in 6 publications (PMIDs: 22742743, 30117111, 22492991, 29356258, 24759841, 28662078) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by a mouse model and a biochemical function assay (PMIDs: 32714760, 10536042). In summary, there is definitive evidence supporting the relationship between DPAGT1 and autosomal recessive congenital disorder of glycosylation. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date June 5, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/15e2fbef-7afa-4aaa-a8a8-69906bfb96f7","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ac9d420c-dfeb-460a-924f-ae80a3203188","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:otherTextChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ac9d420c-dfeb-460a-924f-ae80a3203188_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-08-08T14:15:38.593Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/ac9d420c-dfeb-460a-924f-ae80a3203188_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-06-17T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration","ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac9d420c-dfeb-460a-924f-ae80a3203188_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/015143b2-4533-4431-8358-fdbb6ab18c42_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/015143b2-4533-4431-8358-fdbb6ab18c42","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","rdfs:label":"Belaya Case 4","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/cfd7d31a-c852-46e1-bd72-8d4d2948726b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.478G>A (p.Gly160Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA229604903"}},{"id":"https://genegraph.clinicalgenome.org/r/a87740d8-c7e4-4ac8-8522-332e4bb7ce3b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.574G>A (p.Gly192Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314599"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012036","obo:HP_0001288","obo:HP_0100301"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5fd3b582-0dbf-4433-a9fc-de17ad348927_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","allele":{"id":"https://genegraph.clinicalgenome.org/r/a87740d8-c7e4-4ac8-8522-332e4bb7ce3b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/85f938e7-593c-4467-9e54-d795e312257e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","allele":{"id":"https://genegraph.clinicalgenome.org/r/cfd7d31a-c852-46e1-bd72-8d4d2948726b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/85f938e7-593c-4467-9e54-d795e312257e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85f938e7-593c-4467-9e54-d795e312257e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/85f938e7-593c-4467-9e54-d795e312257e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in increased enzymatic activity and near-normal stability compared to wt. An RT-PCR assay showed that this variant affects splicing, resulting in exclusively transcripts missing exons 2 and 3.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5fd3b582-0dbf-4433-a9fc-de17ad348927","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5fd3b582-0dbf-4433-a9fc-de17ad348927_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5fd3b582-0dbf-4433-a9fc-de17ad348927_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in less than 25% activity and decreased thermostability (fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/24a685ef-5bb2-41e1-910f-028ed8c42b20_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24a685ef-5bb2-41e1-910f-028ed8c42b20","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28662078","rdfs:label":"Yuste-Checa P1","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/ac0d360f-f9ba-477c-9ffc-92df71bf22c4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.1154T>G (p.Leu385Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA229601834"}},{"id":"https://genegraph.clinicalgenome.org/r/d541ec68-df91-4d24-a1a3-96176db02801","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.901C>T (p.Arg301Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314515"}}],"detectionMethod":"In original publication, ALG6, DPM1, and DOLK were ruled out. Mutations were then found in DPAGT1 by cDNA and genomic DNA sequencing. In this publication, mutations were identified by Sanger, WES, or a CDG panel, but it is not specified which one each patient underwent.","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0001252","obo:HP_0000365","obo:HP_0003642","obo:HP_0000998","obo:HP_0001558"],"previousTesting":true,"previousTestingDescription":"CDG screening showed 19% of carbohydrate-deficient transferrin. Serum transferrin IEF showed type 1 pattern. PMM and PMI activity in patient fibroblasts was normal. ","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f2b10935-50ce-45f4-b5f9-3656aa639b59_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28662078","allele":{"id":"https://genegraph.clinicalgenome.org/r/d541ec68-df91-4d24-a1a3-96176db02801"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/b223214d-116d-4ca5-8408-1b8c6bff60b0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28662078","allele":{"id":"https://genegraph.clinicalgenome.org/r/ac0d360f-f9ba-477c-9ffc-92df71bf22c4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b223214d-116d-4ca5-8408-1b8c6bff60b0","type":"EvidenceLine","dc:description":"Reduced due to conflicting functional evidence.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b223214d-116d-4ca5-8408-1b8c6bff60b0_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b223214d-116d-4ca5-8408-1b8c6bff60b0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunofluorescence showed absence of protein suggesting an effect on protein stability (fig 4). However, increased protein stability was shown in PMID: 30388443. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f2b10935-50ce-45f4-b5f9-3656aa639b59","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2b10935-50ce-45f4-b5f9-3656aa639b59_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/f2b10935-50ce-45f4-b5f9-3656aa639b59_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Protein was properly localized in the ER and appeared stable (immunofluorescence, fig 4). PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in less than 25% activity but similar thermostability (fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/6f4d5eb8-780d-4785-aae4-c251ce88f775_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f4d5eb8-780d-4785-aae4-c251ce88f775","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patient 11","ageType":"AgeAtReport","ageUnit":"Years","ageValue":17,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/7fd16094-02fb-40d6-8f90-48f4a4341647","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.26dup (p.Met9IlefsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314738"}},{"id":"https://genegraph.clinicalgenome.org/r/9eff0507-2c5d-40f3-b051-a199838316bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.739C>T (p.Arg247Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314535"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0010864","obo:HP_0001252","obo:HP_0002650","obo:HP_0003642","obo:HP_0000252"],"previousTesting":true,"previousTestingDescription":"Serum transferrin IEF - type I pattern","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/cb8e3a14-efde-4c94-98b3-a5281184705e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/9eff0507-2c5d-40f3-b051-a199838316bb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/c0320a8d-6d1e-4cb5-962a-a34b9c473c2d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/7fd16094-02fb-40d6-8f90-48f4a4341647"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/cb8e3a14-efde-4c94-98b3-a5281184705e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb8e3a14-efde-4c94-98b3-a5281184705e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c0320a8d-6d1e-4cb5-962a-a34b9c473c2d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0320a8d-6d1e-4cb5-962a-a34b9c473c2d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/ab405133-e397-4f52-bb46-33e137f6bb14_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab405133-e397-4f52-bb46-33e137f6bb14","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","rdfs:label":"Belaya Case 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/af224e8d-5451-4116-9ef0-7e52d5ae067e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.324G>C (p.Met108Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129972"}},{"id":"https://genegraph.clinicalgenome.org/r/3f90f823-d1a5-4c35-ae72-d536cd9eb73b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.349G>A (p.Val117Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129971"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0100301","obo:HP_0002355","obo:HP_0003325"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8c24c5a3-b4fb-442f-81d6-76fa27815e1c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f90f823-d1a5-4c35-ae72-d536cd9eb73b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/9a41e993-c8d1-4061-803e-0300f396873a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","allele":{"id":"https://genegraph.clinicalgenome.org/r/af224e8d-5451-4116-9ef0-7e52d5ae067e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/8c24c5a3-b4fb-442f-81d6-76fa27815e1c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c24c5a3-b4fb-442f-81d6-76fa27815e1c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8c24c5a3-b4fb-442f-81d6-76fa27815e1c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in less than 50% activity but increased thermostability (fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9a41e993-c8d1-4061-803e-0300f396873a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a41e993-c8d1-4061-803e-0300f396873a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/1f178145-589d-4db9-af0a-4b5a4411a576_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f178145-589d-4db9-af0a-4b5a4411a576","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patient 7","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/9eff0507-2c5d-40f3-b051-a199838316bb"},{"id":"https://genegraph.clinicalgenome.org/r/050d7057-a495-44a5-85a0-e283a3dff144","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.380_395dup (p.Ser133AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA477369991"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003642","obo:HP_0000483","obo:HP_0000577"],"previousTestingDescription":"Serum transferrin IEF - type 1 profile","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0e7b0064-c602-4197-a69a-0041499a000b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/050d7057-a495-44a5-85a0-e283a3dff144"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/28e43701-0639-46d1-a46e-be45bf53f192_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/9eff0507-2c5d-40f3-b051-a199838316bb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/0e7b0064-c602-4197-a69a-0041499a000b","type":"EvidenceLine","dc:description":"Predicted to be NMD+","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e7b0064-c602-4197-a69a-0041499a000b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/28e43701-0639-46d1-a46e-be45bf53f192","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28e43701-0639-46d1-a46e-be45bf53f192_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/30c27bc7-cda4-4a7b-8e45-f8f28b96652f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30c27bc7-cda4-4a7b-8e45-f8f28b96652f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patient 6","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/61f5c9da-6bca-487e-b1a0-4188e6a8794f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.419A>G (p.Tyr140Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314639"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0000998","obo:HP_0033725","obo:HP_0002910","obo:HP_0003642","obo:HP_0011097","obo:HP_0200134","obo:HP_0002521"],"previousTestingDescription":"Serum transferrin IEF - type I pattern","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0aa7434b-1232-4e85-943e-a8a086ce49e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/61f5c9da-6bca-487e-b1a0-4188e6a8794f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/0aa7434b-1232-4e85-943e-a8a086ce49e9","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0aa7434b-1232-4e85-943e-a8a086ce49e9_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/509b8aa7-7dbc-418f-8618-1dd1023c319c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/509b8aa7-7dbc-418f-8618-1dd1023c319c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patient 5","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/050d7057-a495-44a5-85a0-e283a3dff144"},{"id":"https://genegraph.clinicalgenome.org/r/b717bcd4-8472-41a1-9eb9-e5a7f92f8c6d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.116_117delinsAA (p.Ala39Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2003810611"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000252","obo:HP_0002910","obo:HP_0001252","obo:HP_0003642","obo:HP_0010864"],"previousTesting":true,"previousTestingDescription":"Serum transferrin IEF - type I pattern","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/66cd6c1d-6c35-4eb1-b11f-8c1eb7af12ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/050d7057-a495-44a5-85a0-e283a3dff144"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/b539e09d-02a1-4eb4-baca-6213f4f46b64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/b717bcd4-8472-41a1-9eb9-e5a7f92f8c6d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/66cd6c1d-6c35-4eb1-b11f-8c1eb7af12ab","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66cd6c1d-6c35-4eb1-b11f-8c1eb7af12ab_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b539e09d-02a1-4eb4-baca-6213f4f46b64","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b539e09d-02a1-4eb4-baca-6213f4f46b64_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/fad0fb9e-420e-4eaf-8ea3-ee5f16f5d164_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fad0fb9e-420e-4eaf-8ea3-ee5f16f5d164","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","rdfs:label":"Belaya Case 3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/b33bc039-14d3-4fa6-8cff-71c71d786098","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.791T>G (p.Val264Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129975"}},{"id":"https://genegraph.clinicalgenome.org/r/0a27175a-623f-407b-97c6-7e4c04a346d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.358C>A (p.Leu120Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129974"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Abnormal levels of serum transferrin glycosylation","phenotypes":["obo:HP_0100301","obo:HP_0001270","obo:HP_0002421","obo:HP_0002650","obo:HP_0001252"],"previousTestingDescription":"Serum transferrin IEF showed type 1 pattern","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a85ea9e6-7e0f-4f89-bcba-316faf7c44b6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","allele":{"id":"https://genegraph.clinicalgenome.org/r/b33bc039-14d3-4fa6-8cff-71c71d786098"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/bd4e9381-75c7-4286-a836-b1be08e9481d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","allele":{"id":"https://genegraph.clinicalgenome.org/r/0a27175a-623f-407b-97c6-7e4c04a346d4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/bd4e9381-75c7-4286-a836-b1be08e9481d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd4e9381-75c7-4286-a836-b1be08e9481d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bd4e9381-75c7-4286-a836-b1be08e9481d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in less than 25% activity but increased thermostability (fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a85ea9e6-7e0f-4f89-bcba-316faf7c44b6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a85ea9e6-7e0f-4f89-bcba-316faf7c44b6_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a85ea9e6-7e0f-4f89-bcba-316faf7c44b6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in increased enzymatic activity and near-normal stability compared to wt. An RT-PCR assay showed that this variant affects splicing, resulting in exons 6 and 7 being excluded from most transcripts (fig S3).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/42d7d52c-508f-4396-84b9-aa4f6759893e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42d7d52c-508f-4396-84b9-aa4f6759893e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patient 2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/e3ecdfc3-a0a9-4379-8f2b-61409bb3e134","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.584C>G (p.Ala195Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279840"}},{"id":"https://genegraph.clinicalgenome.org/r/c5c260ce-dfcd-491e-bff8-996440e2a5a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.509A>G (p.Tyr170Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256258"}}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003642","obo:HP_0001252"],"previousTesting":true,"previousTestingDescription":"Serum transferrin IEF - type I pattern","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d3f886ba-547f-4039-9dbc-8fd0bdf0cd47_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3ecdfc3-a0a9-4379-8f2b-61409bb3e134"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/c6605a0b-7878-4de0-8436-cbc7e3ffed92_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5c260ce-dfcd-491e-bff8-996440e2a5a6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/d3f886ba-547f-4039-9dbc-8fd0bdf0cd47","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3f886ba-547f-4039-9dbc-8fd0bdf0cd47_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c6605a0b-7878-4de0-8436-cbc7e3ffed92","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6605a0b-7878-4de0-8436-cbc7e3ffed92_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c6605a0b-7878-4de0-8436-cbc7e3ffed92_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in less than 25% activity but similar thermostability (fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/baa54317-f267-4cfb-8046-2ab09595e346_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/baa54317-f267-4cfb-8046-2ab09595e346","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","rdfs:label":"Belaya Case 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":7,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c0b4fe83-3598-4163-99a7-7cd4ab15f098","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.699dup (p.Thr234HisfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129973"}},{"id":"https://genegraph.clinicalgenome.org/r/3f90f823-d1a5-4c35-ae72-d536cd9eb73b"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0100301","obo:HP_0002650"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/51b9da59-2f1b-478a-a114-37813e3ea266_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0b4fe83-3598-4163-99a7-7cd4ab15f098"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/3c99c89a-d5ae-4e3d-8ba2-5c9dcb3e2374_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f90f823-d1a5-4c35-ae72-d536cd9eb73b"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/51b9da59-2f1b-478a-a114-37813e3ea266","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51b9da59-2f1b-478a-a114-37813e3ea266_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/51b9da59-2f1b-478a-a114-37813e3ea266_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"HEK293 cells transfected with the variant produced no detectable protein - confirming NMD, but this is not scored as functional data.","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3c99c89a-d5ae-4e3d-8ba2-5c9dcb3e2374","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c99c89a-d5ae-4e3d-8ba2-5c9dcb3e2374_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/b7364d98-509c-4912-b915-296e9d837c24_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7364d98-509c-4912-b915-296e9d837c24","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492991","rdfs:label":"Timal Patient 6","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":30,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/a0385a61-f725-4463-bc95-e23740096563","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.161+5G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261218"}},{"id":"https://genegraph.clinicalgenome.org/r/bf6778dd-20ce-4ba6-a409-1cefd0074c86","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.206T>A (p.Ile69Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261216"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001337","obo:HP_0002828","obo:HP_0012768","obo:HP_0001976","obo:HP_0002104","obo:HP_0011968","obo:HP_0002910","obo:HP_0000952","obo:HP_0100018","obo:HP_0000028","obo:HP_0001903","obo:HP_0003075","obo:HP_0003642","obo:HP_0002093","obo:HP_0001276"],"previousTesting":true,"previousTestingDescription":"Underwent biochemical testing for PMM, PMI, DPM, and N-oligosaccharyltransferase LLO analysis. Direct sequencing of SRD5A3, DHDDS, DOLPP1 were all negative. Serum transferrin IEF showed a type I pattern.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2f89194d-c0fd-4d89-806c-45190ed55a35_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492991","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf6778dd-20ce-4ba6-a409-1cefd0074c86"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/702ba53e-582d-4514-bc07-1b67a4bd54c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492991","allele":{"id":"https://genegraph.clinicalgenome.org/r/a0385a61-f725-4463-bc95-e23740096563"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/702ba53e-582d-4514-bc07-1b67a4bd54c7","type":"EvidenceLine","dc:description":"Scoring at default for null variant, cDNA Sanger sequencing showed that this transcript likely undergoes NMD.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/702ba53e-582d-4514-bc07-1b67a4bd54c7_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2f89194d-c0fd-4d89-806c-45190ed55a35","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f89194d-c0fd-4d89-806c-45190ed55a35_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2f89194d-c0fd-4d89-806c-45190ed55a35_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in less than 50% activity but increased thermostability (fig 4).\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/ef4af26b-956d-4871-91fc-e61f116f69a5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef4af26b-956d-4871-91fc-e61f116f69a5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patient 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ead12cda-0fe9-4608-9074-d04404a35264","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.2T>C (p.Met1Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA382917649"}},{"id":"https://genegraph.clinicalgenome.org/r/b20bdfea-d487-40a2-8f62-8fb7ee45c80a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.341C>G (p.Ala114Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA264781"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0000998","obo:HP_0000252","obo:HP_0002910","obo:HP_0003642","obo:HP_0000486","obo:HP_0009125"],"previousTesting":true,"previousTestingDescription":"Serum transferrin IEF - type I pattern, normal MRI","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d1d8d175-98fc-4c3f-bc60-86c29d831202_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/ead12cda-0fe9-4608-9074-d04404a35264"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/054ad997-a802-4181-bb6b-f009a54f9ace_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/b20bdfea-d487-40a2-8f62-8fb7ee45c80a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/054ad997-a802-4181-bb6b-f009a54f9ace","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/054ad997-a802-4181-bb6b-f009a54f9ace_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/054ad997-a802-4181-bb6b-f009a54f9ace_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in less than 50% activity but increased thermostability (fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d1d8d175-98fc-4c3f-bc60-86c29d831202","type":"EvidenceLine","dc:description":"This start loss was scored as a \"Other\" variant because there is another methionine at codon 9. Per PMID: 24759841 loss of the first methionine truncates the signal peptide and decreases the molecular weight of the protein, but a protein is still produced.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1d8d175-98fc-4c3f-bc60-86c29d831202_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/0bb73cab-cb9e-43a9-a746-bdee86caa128_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bb73cab-cb9e-43a9-a746-bdee86caa128","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24759841","rdfs:label":"Selcen Patient 2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/d3685d75-4ae2-4d65-8cad-6b9a5e7cfa3a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.360G>C (p.Leu120=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314645"}},{"id":"https://genegraph.clinicalgenome.org/r/dd584aad-15f3-418b-a561-5cf9f38c2cae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.790G>A (p.Val264Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314530"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003642","obo:HP_0100301","obo:HP_0011968","obo:HP_0001270","obo:HP_0003325"],"previousTesting":true,"previousTestingDescription":"Negative AChR and MuSK antibody tests, normal serum creatine kinase levels, and normal brain MRI.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5024c9a8-51fa-460e-980d-423ef46942ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24759841","allele":{"id":"https://genegraph.clinicalgenome.org/r/d3685d75-4ae2-4d65-8cad-6b9a5e7cfa3a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/cf6d2b55-c6ce-4528-9ab7-24727e58598d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24759841","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd584aad-15f3-418b-a561-5cf9f38c2cae"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/cf6d2b55-c6ce-4528-9ab7-24727e58598d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf6d2b55-c6ce-4528-9ab7-24727e58598d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cf6d2b55-c6ce-4528-9ab7-24727e58598d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Enzyme activity as measured in transfected COS-7 cells was reduced to 0.41 compared to wt which was 31.44. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5024c9a8-51fa-460e-980d-423ef46942ce","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5024c9a8-51fa-460e-980d-423ef46942ce_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5024c9a8-51fa-460e-980d-423ef46942ce_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"DPAGT1 was sequenced from cDNA isolated from the patient's muscle and from 2 normal control muscles. This revealed an exon 2 and 3 skipped transcript (T-2,3) in both patient and control cDNAs, but the T-2,3 transcript was present at a 10-fold-higher level in patient 2 than in the controls. Whole cDNA was also cloned from patient 2; this revealed that 4 of 41 clones harbored the unskipped synonymous Leu120 transcript. Genomic DNA containing exons 2 to 4 with flanking intronic regions was cloned and the cDNA extract from transfected COS-7 cells analyzed. cDNA from the wild-type allele displayed a strong band corresponding to the unskipped segment and a weak band representing T-2,3, whereas cDNA from the mutant allele harbored the T-2,3 transcript exclusively.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/90e8c849-5013-4810-93a1-9f0f5f239ec7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90e8c849-5013-4810-93a1-9f0f5f239ec7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28662078","rdfs:label":"Yuste-Checa P3","allele":[{"id":"https://genegraph.clinicalgenome.org/r/dcc24af5-55fb-4c53-a729-8a7db8ffbf7e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.902G>A (p.Arg301His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314514"}},{"id":"https://genegraph.clinicalgenome.org/r/7cda089c-cb91-43b0-a051-06bb7c2d3ade","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.329T>C (p.Phe110Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA382915310"}}],"detectionMethod":"Paper notes that genetic analyses were performed by Sanger, WES, or a 43-gene NGS CDG panel, however, it does not specify the specific technique used for each patient.","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0003325","obo:HP_0001270","obo:HP_0001252","obo:HP_0000365"],"previousTesting":false,"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/92f445e1-88c0-4f1f-a16a-55d3a3667063_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28662078","allele":{"id":"https://genegraph.clinicalgenome.org/r/dcc24af5-55fb-4c53-a729-8a7db8ffbf7e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/95eab6a5-3daf-4338-a20f-29ea0d7c67af_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28662078","allele":{"id":"https://genegraph.clinicalgenome.org/r/7cda089c-cb91-43b0-a051-06bb7c2d3ade"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/95eab6a5-3daf-4338-a20f-29ea0d7c67af","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95eab6a5-3daf-4338-a20f-29ea0d7c67af_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/95eab6a5-3daf-4338-a20f-29ea0d7c67af_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In transfected COS7 cells, protein quantity reduced by 30% compared to wt (fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/92f445e1-88c0-4f1f-a16a-55d3a3667063","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92f445e1-88c0-4f1f-a16a-55d3a3667063_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/92f445e1-88c0-4f1f-a16a-55d3a3667063_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 30388443 performed enzyme activity and thermostability assays on this variant. This variant was found to result in less than 25% activity but similar thermostability (fig 4).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/00476f40-80ce-45c5-97d9-8ecaa9bc6949_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00476f40-80ce-45c5-97d9-8ecaa9bc6949","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29356258","rdfs:label":"Bogdanova III-1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/46377f13-0f47-4b2b-93b4-374a46070665","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.135_136del (p.Leu46GlnfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314724"}},{"id":"https://genegraph.clinicalgenome.org/r/1e40591d-741e-4f11-82c0-c68ed870239a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.367C>T (p.Arg123Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA229605078"}}],"detectionMethod":"The paper notes that DPAGT1 was sequenced but it is not clear by what technique nor is it clear how the variants were confirmed.","firstTestingMethod":"Other","previousTestingDescription":"Mildly elevated creatine kinase. Muscle biopsy with some fiber size variation and atrophic fibers. Single-fiber electronmyography studies demonstrated \"excessive jitter and block from extensor digitorum communis.\"","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f92b1a75-f1fe-43ec-983f-87d8723b7efb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29356258","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e40591d-741e-4f11-82c0-c68ed870239a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/2482ecc3-a40f-4eae-969d-531e344cf5da_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29356258","allele":{"id":"https://genegraph.clinicalgenome.org/r/46377f13-0f47-4b2b-93b4-374a46070665"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/2482ecc3-a40f-4eae-969d-531e344cf5da","type":"EvidenceLine","dc:description":"Elected not to score this case given the unclear sequencing methods.","calculatedScore":1.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2482ecc3-a40f-4eae-969d-531e344cf5da_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f92b1a75-f1fe-43ec-983f-87d8723b7efb","type":"EvidenceLine","dc:description":"Elected not to score this case given the unclear sequencing methods.","calculatedScore":0.1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f92b1a75-f1fe-43ec-983f-87d8723b7efb_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/5ad5f72d-0a78-4994-b117-98823fb952fb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ad5f72d-0a78-4994-b117-98823fb952fb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24759841","rdfs:label":"Selcen Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/6ead3129-ed7e-471f-a828-94101acc6c3b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.1A>C (p.Met1Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16606252"}},{"id":"https://genegraph.clinicalgenome.org/r/e65ef353-bb6e-46df-8b22-f1a54ecb152f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.1123C>T (p.His375Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6314458"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0011968","obo:HP_0002342","obo:HP_0001252","obo:HP_0002421"],"previousTesting":true,"previousTestingDescription":"Negative AChR and MuSK antibody tests, normal serum creatine kinase levels, and normal brain MRI.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a538b59f-75cf-4617-83bc-3e5b68dcaefb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24759841","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ead3129-ed7e-471f-a828-94101acc6c3b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/52049d06-add6-45f0-811b-d14d2d30feab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24759841","allele":{"id":"https://genegraph.clinicalgenome.org/r/e65ef353-bb6e-46df-8b22-f1a54ecb152f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/a538b59f-75cf-4617-83bc-3e5b68dcaefb","type":"EvidenceLine","dc:description":"Scored as an \"other\" variant because there is an alternate Met at codon 9. which if used would truncate the signal peptide but leave the majority of the protein intact. Protein expression was reduced to 39%. Enzyme activity measured in COS-7 cells was not significantly different from wt. Per authors this could be due to the assay being done on whole homogenate which may not reflect N-glycosylation in vivo. Muscle extract of patient 1 showed virtual absence of 70-kDa N- and O-glycosylated proteins.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a538b59f-75cf-4617-83bc-3e5b68dcaefb_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/52049d06-add6-45f0-811b-d14d2d30feab","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52049d06-add6-45f0-811b-d14d2d30feab_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/52049d06-add6-45f0-811b-d14d2d30feab_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Enzyme activity reduced to 18.5 compared to wt (32.4) in transfected COS-7 cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/ac9d420c-dfeb-460a-924f-ae80a3203188_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/527ccd1e-30d9-4a22-80f1-66bb9e982148_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough affected individuals in family.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24759841","rdfs:label":"Selcen Family 1","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/527ccd1e-30d9-4a22-80f1-66bb9e982148","type":"Family","rdfs:label":"Selcen Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/5ad5f72d-0a78-4994-b117-98823fb952fb"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001657","obo:HP_0002650","obo:HP_0100301","obo:HP_0003325"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5ad5f72d-0a78-4994-b117-98823fb952fb"}},{"id":"https://genegraph.clinicalgenome.org/r/7793ad15-f1fc-4118-8d01-4d48aaeaf437_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29356258","rdfs:label":"Bogdanova Family","family":{"id":"https://genegraph.clinicalgenome.org/r/7793ad15-f1fc-4118-8d01-4d48aaeaf437","type":"Family","rdfs:label":"Bogdanova Family","member":{"id":"https://genegraph.clinicalgenome.org/r/00476f40-80ce-45c5-97d9-8ecaa9bc6949"}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0003325","obo:HP_0001256"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/00476f40-80ce-45c5-97d9-8ecaa9bc6949"}},{"id":"https://genegraph.clinicalgenome.org/r/bc02e82c-5385-4312-b92d-68fe9ed60ebb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patient 2 and 3","family":{"id":"https://genegraph.clinicalgenome.org/r/bc02e82c-5385-4312-b92d-68fe9ed60ebb","type":"Family","rdfs:label":"Ng Patient 2 and 3","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/42d7d52c-508f-4396-84b9-aa4f6759893e"}},"phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0002170","proband":{"id":"https://genegraph.clinicalgenome.org/r/42d7d52c-508f-4396-84b9-aa4f6759893e"}},{"id":"https://genegraph.clinicalgenome.org/r/8951a72a-997c-4bf4-9fea-320a3963c43d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22742743","rdfs:label":"Belaya Cases 3 and 5","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/8951a72a-997c-4bf4-9fea-320a3963c43d","type":"Family","rdfs:label":"Belaya Cases 3 and 5","member":{"id":"https://genegraph.clinicalgenome.org/r/fad0fb9e-420e-4eaf-8ea3-ee5f16f5d164"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001270","obo:HP_0001252"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/fad0fb9e-420e-4eaf-8ea3-ee5f16f5d164"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/fa393a96-05ea-4782-9178-5c07ea9db182_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patients 7 and 8","family":{"id":"https://genegraph.clinicalgenome.org/r/fa393a96-05ea-4782-9178-5c07ea9db182","type":"Family","rdfs:label":"Ng Patients 7 and 8","member":{"id":"https://genegraph.clinicalgenome.org/r/1f178145-589d-4db9-af0a-4b5a4411a576"}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002910","obo:HP_0010864","obo:HP_0001252"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1f178145-589d-4db9-af0a-4b5a4411a576"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/dc032bc0-37c7-4d03-93b3-cabaea9de358_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc032bc0-37c7-4d03-93b3-cabaea9de358","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","rdfs:label":"Ng Patient 4","allele":[{"id":"https://genegraph.clinicalgenome.org/r/bae15270-acf8-4c6c-9ba9-82cdaff0832f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.1117C>G (p.Pro373Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA382908173"}},{"id":"https://genegraph.clinicalgenome.org/r/34214083-a08f-40bc-958d-178c61bcf63b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001382.4(DPAGT1):c.1197T>A (p.Tyr399Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA382907423"}}],"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003642","obo:HP_0001989","obo:HP_0002304","obo:HP_0012050"],"previousTesting":true,"previousTestingDescription":"Serum transferrin IEF - type I pattern","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ff09ac4c-0441-4e0a-a4af-3ea84832cb2e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/bae15270-acf8-4c6c-9ba9-82cdaff0832f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/ceb2a74f-fac3-46af-b61b-afe15ae57b30_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30117111","allele":{"id":"https://genegraph.clinicalgenome.org/r/34214083-a08f-40bc-958d-178c61bcf63b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/ceb2a74f-fac3-46af-b61b-afe15ae57b30","type":"EvidenceLine","dc:description":"Downgraded because this is a nonsense variant in the last exon and is not expected to result in nonsense-mediated decay.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ceb2a74f-fac3-46af-b61b-afe15ae57b30_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ff09ac4c-0441-4e0a-a4af-3ea84832cb2e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff09ac4c-0441-4e0a-a4af-3ea84832cb2e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/ac9d420c-dfeb-460a-924f-ae80a3203188_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac9d420c-dfeb-460a-924f-ae80a3203188_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/561f3aff-124e-4133-ae59-d38d118cdfdc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2789130f-e3cd-4ec3-96b9-7f37c8eab01f","type":"Finding","dc:description":"DPAGT1 catalyzes the first step in the dolichol cycle, which initiates the process of N-linked glycosylation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10536042","rdfs:label":"Marek GPT Activity ","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ac9d420c-dfeb-460a-924f-ae80a3203188_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50080245-631b-402b-a5d0-651a4c2eebdf","type":"EvidenceLine","dc:description":"No recapitulation of human phenotype.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1414413-bedd-47ed-830b-b9517313589c","type":"Finding","dc:description":"Retinal degeneration has not been observed in humans with DPAGT1 mutations. In addition, the homozygous missense model showed normal N-glycosylation of retinal proteins compared to wt mice. Finally, homozygous missense mice do not exhibit muscular abnormalities as are found in humans with DPAGT1 mutations.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36233305","rdfs:label":"Hyde Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/05e7102a-6f53-4f58-8a89-bbb3cc40cdbb","type":"EvidenceLine","dc:description":"Decreased due to primary focus on oocyte development and fertility, which are not phenotypes associated with human disease.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1cc93ca-bfd6-4e81-9ae1-cc92f1fdca1b","type":"Finding","dc:description":"While decreased fertility has not been noted in humans with DPAGT1 mutations (likely due to most patients not reaching reproductive age), the decreased N-glycosylation of the zona pellucida (a coating on vertebrate oocytes) is consistent with decreased N-glycosylation in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32714760","rdfs:label":"Li Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Definitive","sequence":8783,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/7pRvK1FHTo8","type":"GeneValidityProposition","disease":"obo:MONDO_0011964","gene":"hgnc:2995","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ac9d420c-dfeb-460a-924f-ae80a3203188-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}